Published in Presse Med on February 07, 1987
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science (1993) 9.11
Development of a preventive vaccine for Ebola virus infection in primates. Nature (2000) 8.32
Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl J Med (1994) 7.61
The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 7.39
Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 6.72
Lassa fever. Effective therapy with ribavirin. N Engl J Med (1986) 6.38
Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med (1999) 5.85
Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis (1999) 5.59
A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis (1987) 5.27
Human asymptomatic Ebola infection and strong inflammatory response. Lancet (2000) 5.20
Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. J Infect Dis (1994) 4.97
Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.96
Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ (1983) 4.81
Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children. Am J Trop Med Hyg (1999) 4.24
Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis (1997) 4.03
ELISA for the detection of antibodies to Ebola viruses. J Infect Dis (1999) 3.92
A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis (1987) 3.51
Patterns of association with host and habitat: antibody reactive with Sin Nombre virus in small mammals in the major biotic communities of the southwestern United States. Am J Trop Med Hyg (1997) 3.46
Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 3.36
Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet (1999) 3.24
Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ (1995) 3.21
Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J Virol (1985) 3.06
Genetic diversity among Lassa virus strains. J Virol (2000) 3.00
A case-control study of hantavirus pulmonary syndrome during an outbreak in the southwestern United States. J Infect Dis (1995) 2.95
Clinical virology of Lassa fever in hospitalized patients. J Infect Dis (1987) 2.94
Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis (1999) 2.76
Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J Clin Microbiol (1992) 2.69
Molecular investigation of a multisource outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates. Am J Trop Med Hyg (1997) 2.66
Descriptive analysis of Ebola virus proteins. Virology (1985) 2.65
Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis (1996) 2.64
Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology (2000) 2.63
Lassa fever in the United States. Investigation of a case and new guidelines for management. N Engl J Med (1990) 2.57
Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome. Virus Res (1993) 2.57
Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation. J Clin Microbiol (1982) 2.44
Spatial and temporal patterns of Zaire ebolavirus antibody prevalence in the possible reservoir bat species. J Infect Dis (2007) 2.37
Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. Bull World Health Organ (2000) 2.33
The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiol Infect (1997) 2.27
Brief report: treatment of a laboratory-acquired Sabiá virus infection. N Engl J Med (1995) 2.27
Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am J Trop Med Hyg (1995) 2.26
Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996. J Infect Dis (1999) 2.22
Pathologic and virologic study of fatal Lassa fever in man. Am J Pathol (1982) 2.14
Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes. Lancet (1984) 2.12
Pathogenesis of a North American hantavirus, Black Creek Canal virus, in experimentally infected Sigmodon hispidus. Am J Trop Med Hyg (1998) 2.11
Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect (2006) 2.09
Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations. Vector Borne Zoonotic Dis (2001) 2.07
Isolation of the causative agent of hantavirus pulmonary syndrome. Am J Trop Med Hyg (1994) 2.07
A real-time RT-PCR method for the universal detection and identification of flaviviruses. Vector Borne Zoonotic Dis (2007) 2.05
Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates. J Infect Dis (1999) 2.04
Hantavirus pulmonary syndrome in Panama: identification of novel hantaviruses and their likely reservoirs. Virology (2000) 2.03
Acute sensorineural deafness in Lassa fever. JAMA (1990) 2.02
Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro. Virology (2001) 1.97
A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 1.96
Biologic differences between strains of Ebola virus from Zaire and Sudan. J Infect Dis (1983) 1.94
Junin virus monoclonal antibodies: characterization and cross-reactivity with other arenaviruses. J Gen Virol (1989) 1.92
Genetic investigation of novel hantaviruses causing fatal HPS in Brazil. J Med Virol (1999) 1.92
Filoviridae: a taxonomic home for Marburg and Ebola viruses? Intervirology (1982) 1.89
A comparison of methods for counting viruses in aquatic systems. Appl Environ Microbiol (2000) 1.89
Isolation and characterization of Whitewater Arroyo virus, a novel North American arenavirus. Virology (1996) 1.87
A serological survey of Ebola virus infection in central African nonhuman primates. J Infect Dis (2004) 1.86
Diagnosis of Ebola haemorrhagic fever by RT-PCR in an epidemic setting. J Med Virol (2000) 1.79
Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and effect on clinical laboratory analyses. J Clin Microbiol (1984) 1.78
A household-based, case-control study of environmental factors associated with hantavirus pulmonary syndrome in the southwestern United States. Am J Trop Med Hyg (1995) 1.78
A newly recognized virus associated with a fatal case of hantavirus pulmonary syndrome in Louisiana. J Virol (1995) 1.76
Identification of Rickettsia spp. and Bartonella spp. in ffrom the Thai-Myanmar border. Ann N Y Acad Sci (2003) 1.76
Genetic diversity and distribution of Peromyscus-borne hantaviruses in North America. Emerg Infect Dis (1999) 1.74
Effective vaccine for lassa fever. J Virol (2000) 1.74
Crimean Congo-haemorrhagic fever treated with oral ribavirin. Lancet (1995) 1.72
Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA. Virology (1986) 1.69
Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication. J Virol (2001) 1.68
Evaluation of the polymerase chain reaction for diagnosis of Lassa virus infection. Am J Trop Med Hyg (1993) 1.66
Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections. Science (1987) 1.66
Nipah virus outbreak with person-to-person transmission in a district of Bangladesh, 2007. Epidemiol Infect (2010) 1.65
Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation. J Clin Microbiol (2000) 1.63
[Laryngoscope. Evaluation of a device for preventing blade contamination]. Ann Fr Anesth Reanim (1999) 1.63
An outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates, 1994-1995. Am J Trop Med Hyg (1997) 1.62
Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch Pathol Lab Med (1997) 1.60
Rift Valley fever epizootic in the central highlands of Madagascar. Res Virol (1993) 1.59
Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men. Am Heart J (2000) 1.58
Wound infection by an indigenous Pseudomonas pseudomallei-like organism isolated from the soil: case report and epidemiologic study. J Infect Dis (1977) 1.57
A survey of Nipah virus infection among various risk groups in Singapore. Epidemiol Infect (2002) 1.57
Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. Emerg Infect Dis (1997) 1.56
Hantavirus transmission in the United States. Emerg Infect Dis (1997) 1.55
Subgroups, serotypes, and electrophoretypes of rotavirus isolated from children in Bangui, Central African Republic. J Clin Microbiol (1988) 1.54
Human and rodent hantavirus infection in New York State: public health significance of an emerging infectious disease. Arch Intern Med (1996) 1.53
Human-to-human transmission of Pseudomonas pseudomallei. Ann Intern Med (1975) 1.52
A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. BMJ (1988) 1.51
Detection and genetic differentiation of human astroviruses: phylogenetic grouping varies by coding region. Arch Virol (1997) 1.51
Evidence against person-to-person transmission of hantavirus to health care workers. Clin Infect Dis (1996) 1.50
Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells. J Virol (2001) 1.50
Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission I. Description of study site, general methodology, and study population. Am J Trop Med Hyg (1999) 1.49
Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. Clin Infect Dis (1997) 1.48
Molecular characterization of the polymerase gene and genomic termini of Nipah virus. Virology (2001) 1.47
Hepatitis G virus in Karachi, Pakistan. Lancet (1996) 1.47
A survey of hantavirus antibody in small-mammal populations in selected United States National Parks. Am J Trop Med Hyg (1998) 1.47
Risk factors for Nipah virus encephalitis in Bangladesh. Emerg Infect Dis (2008) 1.45
The nucleoprotein gene of Ebola virus: cloning, sequencing, and in vitro expression. Virology (1989) 1.42
Reemergence of Ebola virus in Africa. Emerg Infect Dis (1996) 1.40